Physician
Infectious Disease
Dr. Michael S. Bronze, MD
|
|
Give Review
Michael Bronze is an expert in the field of Infectious Disease. He attended University of Tennessee College of Medicine. Dr. Michael S. Bronze is a published doctor as well. He has 90 publications published. The latest was: Urinary tract aspergillosis in a renal transplant recipient. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Journey of a Strut: From Filter to Missile.
- Histoplasma Infection of Aortofemoral Bypass Graft.
- Risk of Nocardial Infections With Anti-tumor Necrosis Factor Therapy.
- Primary Retroperitoneal Abscess Caused by Candida glabrata.
- Prophylactic Vaccine Approach for Colon and Pancreatic Cancers: Present and Future.
- Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.
- Refractory hypoxia in an HIV-infected patient-a diagnostic challenge.
- Internal medicine residency redesign.
- Emerging pathogens and knowledge in infectious diseases.
- Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections.
- Infectious agents of food- and water-borne illnesses.
- Infection caused by Rahnella aquatilis.
- Hepatitis C prevalence in patients with hepatocellular carcinoma without cirrhosis.
- Osteoporosis in inflammatory bowel disease.
- Induction of cardiovascular pathology in a novel model of low-grade chronic inflammation.
- Mycobacterium bovis infection of an axillary-femoral bypass graft after intravesical bacille Calmette-Guérin immunotherapy for bladder cancer.
- Blood smear analysis in babesiosis, ehrlichiosis, relapsing fever, malaria, and Chagas disease.
- Innate responses to systemic infection by intracellular bacteria trigger recruitment of Ly-6Chigh monocytes to the brain.
- A confusing case of confusion. Acute porphyrias.
- Gatifloxacin-associated hypoglycemia.
- Part XV. Antiretroviral therapy for human immunodeficiency virus infection.
- Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza.
- Part XIII. Systemic antifungal therapy.
- Part XI. Trimethoprim-sulfamethoxazole, nitrofurantoin, chloramphenicol, metronidazole and tinidazole, rifaximin, and nitazoxanide.
- Part X. Tetracycline and glycylcycline antimicrobials.
- Part IX. Quinolone antimicrobials.
- Antimicrobial symposium. Part VIII. Glycopeptides, oxazolidinones, and lipopeptides.
- Part VII. Macrolides, azalides, ketolides, lincosamides, and streptogramins.
- Antimicrobial symposium. Part VI. Aminoglycosides and polymyxins.
- Part V. Other beta-lactam antimicrobials.
- Antimicrobial symposium. Part IV. Cephalosporins.
- Part III. Penicillins.
- Part II. Introduction to the beta-lactam antibiotics.
- Antimicrobial symposium. Part 1. Principles of antimicrobial therapy.
- Address of the president of the Southern Society for Clinical Investigation: on the importance of mentoring.
- Clinical problem-solving. Still consider the source.
- Infectious Aortitis.
- Overview and management of obesity in adults.
- Clinical problem-solving. Step by step.
- Terrorism symposium update and conclusion.
- Other bacterial diseases as a potential consequence of bioterrorism: Q fever, brucellosis, glanders, and melioidosis.
- The potential role of viral pathogens as agents of bioterrorism.
- Influenza virus: natural disease and bioterrorism threat.
- Symposium introduction: clinical aspects of terrorism.
- Microbiological, biological, and chemical weapons of warfare and terrorism.
- Viral agents as biological weapons and agents of bioterrorism.
- Bacterial pathogens as biological weapons and agents of bioterrorism.
- Terrorism from a public health perspective.
- Fluvastatin Interferes with Hepatitis C Virus Replication via Microtubule Bundling and a Doublecortin-like Kinase-Mediated Mechanism.
- Competency-based education and training in internal medicine.
- Robert Koch and the ''golden age'' of bacteriology.
- Current therapy and the development of therapeutic options for the treatment of diseases due to bacterial agents of potential biowarfare and bioterrorism.
- Preventive and therapeutic approaches to viral agents of bioterrorism.
- Prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents.
- Listeria monocytogenes: epidemiology, human disease, and mechanisms of brain invasion.
- Therapeutic options for diseases due to potential viral agents of bioterrorism.
- Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses.
- Lipoteichoic acid and M protein: dual adhesins of group A streptococci.
- Epitopes of group A streptococcal M protein shared with antigens of articular cartilage and synovium.
- Intramedullary tuberculomas of the spinal cord: case report and review.
- Protective and heart-crossreactive epitopes located within the NH2 terminus of type 19 streptococcal M protein.
- Protective and heart-cross-reactive epitopes of type 19 streptococcal M protein.
- Protective immunity evoked by locally administered group A streptococcal vaccines in mice.
- Pathogenesis of group A streptococci in mice and efficacy of locally administered streptococcal vaccines.
- Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain.
- Analysis of the role of M24 protein in group A streptococcal adhesion and colonization by use of omega-interposon mutagenesis.
- Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice.
- Passive protection of mice against group A streptococcal pharyngeal infection by lipoteichoic acid.
- The reemergence of serious group A streptococcal infections and acute rheumatic fever.
- Case report: Candida zeylanoides infective endocarditis complicating infection with the human immunodeficiency virus.
- Adherence of Streptococcus uberis to bovine mammary epithelial cells and to extracellular matrix proteins.
- Infective endocarditis caused by Streptococcus pneumoniae with high-level resistance to penicillin and cephalosporin.
- Group G streptococcal arthritis: case report and review of the literature.
- Impending paradoxical embolism.
- Immunoblastic lymphadenopathy presenting as an acute abdomen and mixed bacteremia with Eikenella corrodens and group C streptococci.
- Citrobacter freundii empyema in a patient with occult pulmonary histoplasmosis.
- False-positive enzyme immunoassay for human immunodeficiency virus due to acute cytomegalovirus infection.
- Urinary tract aspergillosis in a renal transplant recipient.
- Isoniazid drug and food interactions.
- Effects of cytokines and endotoxin on the intracellular growth of bacteria.
- Infectious aortitis: an uncommon manifestation of infection with Streptococcus pneumoniae.
- Sternal osteomyelitis caused by mycobacterium tuberculosis: case report and review of the literature.
- Enhanced extracellular growth of Staphylococcus aureus in the presence of selected linear peptide fragments of human interleukin (IL)-1beta and IL-1 receptor antagonist.
- Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus.
- Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation.
- Viral infections in patients with inflammatory bowel disease on immunosuppressants.
- Protective and autoimmune epitopes of streptococcal M proteins.
- Effects of methylprednisolone on intracellular bacterial growth.
- Clinical use of anti-TNF therapy and increased risk of infections.
Schools
University Of Tennessee Health Science Center College Of Medicine
University Tenn College Med
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
University of Tennessee -
University of Tennessee College of Medicine
Drug Facts
| NPI NUMBER | 1235199209 | |
| NPPES Provider LastName | BRONZE | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 731045417 | |
| NPPES Provider State | OK | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 439.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 37.0 | |
| Percent Opioid Claims | 8.43 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1235199209 |
| Last Name Of The Provider | BRONZE |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Hanna A. Saadah, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Clifford G. Wlodaver, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bushra Siddique, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amna Yaqub, MD |
|
|
Dr. Leonard N. Slater, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda J. Salinas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen K. Kinney, MD |
|
|
Dr. Mark M. Huycke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deeksha L. Dewan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George Kurdgelashvili, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle R. Salvaggio, MD
This Doctor is OpenDoctor Recommended.
|